Filing Details

Accession Number:
0001773751-24-000098
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-08 18:33:34
Reporting Period:
2024-04-04
Accepted Time:
2024-04-08 18:33:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1773751 Hims & Hers Health Inc. HIMS Services-Offices & Clinics Of Doctors Of Medicine (8011) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1837796 Andrew Dudum 2269 Chestnut Street, #523
San Francisco CA 94123
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2024-04-04 188,888 $2.43 188,888 No 4 M Direct
Class A Common Stock Disposition 2024-04-04 93,521 $14.96 95,367 No 4 S Direct
Class A Common Stock Disposition 2024-04-04 923 $15.63 94,444 No 4 S Direct
Class A Common Stock Disposition 2024-04-04 93,434 $14.97 1,010 No 4 S Direct
Class A Common Stock Disposition 2024-04-04 1,010 $15.63 0 No 4 S Direct
Class A Common Stock Disposition 2024-04-04 128,546 $14.70 1,470,764 No 4 S Indirect Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
Class A Common Stock Disposition 2024-04-04 15,898 $15.39 1,454,866 No 4 S Indirect Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
No 4 S Indirect Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Stock Option (right to buy) Disposition 2024-04-04 188,888 $0.00 188,888 $2.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,526,232 2030-06-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 1,675,943 Indirect Held by Trustee of AD 2021 GRAT dated 11-1-2021
Class A Common Stock 418,986 Indirect Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021
Class A Common Stock 597,335 Indirect Held by Trustee of AD 2022 GRAT
Class A Common Stock 891,735 Indirect Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
Class A Common Stock 1,315,881 Indirect Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022
Class A Common Stock 1,584,506 Indirect Held by Trustee of AD 2023 GRAT dated 9-5-2023
Class A Common Stock 570,398 Indirect Held by Trustee of Dudum Family Community Property Trust
Class A Common Stock 1,500 Indirect Held by Trustees of Richard M. Dudum Irrevocable 1 U/A dtd 10/15/1997
Class A Common Stock 2,874,769 Indirect Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021
Footnotes
  1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.
  2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.44 - 15.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.47 - 15.66. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  4. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.45 - 15.43. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  5. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.47 - 15.685. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  6. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.20 - 15.17. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  7. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.28 - 15.71. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  8. Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.